Pliant Therapeutics Inc
(NAS:PLRX)
$
10.71
-0.49 (-4.38%)
Market Cap: 646.09 Mil
Enterprise Value: 218.36 Mil
PE Ratio: 0
PB Ratio: 1.48
GF Score: 34/100 - Pliant Therapeutics Inc INTEGRIS-PSC Phase 2a Trial Results Call TranscriptFeb 05, 2024
- Pliant Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Pliant Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Pliant Therapeutics Inc INTEGRIS-PSC Interim Phase 2a Data Presentation TranscriptSep 26, 2023
- Pliant Therapeutics Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2023
- Pliant Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Pliant Therapeutics Inc INTEGRIS-IPF Call TranscriptMay 01, 2023
- Pliant Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 19, 2023
- Pliant Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Pliant Therapeutics Inc at Cowen Health Care Conference TranscriptMar 08, 2023
- Pliant Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 15, 2023
- Pliant Therapeutics Inc Review Data from the 320 mg Group of the INTEGRIS-IPF Phase 2a Trial of Bexotegrast (PLN-74809) in Patients with IPF Call TranscriptJan 23, 2023
- Pliant Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Pliant Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Pliant Therapeutics Inc at RBC Capital Markets Biotech Expert Insights: Pulmonary/Lung Disease Mini-Symposium (Virtual) TranscriptOct 07, 2022
- Pliant Therapeutics Inc to Discuss Results from INTEGRIS-IPF Call TranscriptJul 11, 2022
- Pliant Therapeutics Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Pliant Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 18, 2022
- Pliant Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
Pliant Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Feb 15, 2023 / 08:40PM GMT
Release Date Price:
$31.31
(+0.38%)
Mike Kratky
SVB Securities LLC - Analyst
All right. Good afternoon, everyone. Thanks for joining us here at the SVB Securities Global Biopharma Conference. My name is Mike Kratky. I'm a vice president here at SVB Securities. And I'm very happy to be hosting Pliant today. And joining us from the company are CFO Keith Cummings and CMO Ãric Lefebvre.
So one housekeeping note just before we get going here. For investors joining on webcast, feel free to just submit questions via the webcast portal or just email me directly at [email protected].
So Keith and Ãric, thanks for joining.
Ã;ric Lefebvre
Pliant Therapeutics, Inc. - Chief Medical Officer
Thank you. Pleasure.
Keith Cummings
Pliant Therapeutics, Inc. - CFO
Thanks, Mike.
Mike Kratky
SVB Securities LLC - Analyst
So I think everyone is fairly familiar with the story at this point. But would you mind just giving a quick summary and overview of Pliant for those in the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)